Clinical Trial Update: Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the safety and immune response of the cow/human parainfluenza virus vaccine rB/HPIV3 in healthy infants, children, and adults; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parainfluenza Virus Infections

Drugs mentioned

• rB/HPIV3 vaccine (recombinant bovine/human parainfluenza virus type 3 vaccine (rB/HPIV3))

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Paramyxoviridae Infections, Virus Diseases | Phase 1 | Status: COMPLETED